Related topics: melanoma
Skin cancer
hideSkin cancer is a malignant growth on the skin which can have many causes. The most common skin cancers are basal cell cancer, squamous cell cancer, and melanoma. Skin cancer generally develops in the epidermis (the outermost layer of skin), so a tumor is usually clearly visible. This makes most skin cancers detectable in the early stages. There are three common and likely types of skin cancer, each of which is named after the type of skin cell from which it arises. Unlike many other cancers, including those originating in the lung, pancreas, and stomach, only a small minority of those afflicted will actually die of the disease. Skin cancer represents the most commonly diagnosed cancer, surpassing lung, breast, colorectal and prostate cancer. Melanoma is less common than basal cell carcinoma and squamous cell carcinoma, but it is the most serious—for example, in the UK there are 9,500 new cases of melanoma each year, and 2,300 deaths. More people now die of melanoma in the UK than in Australia. It is the most common cancer in the young population (20 – 39 age group). It is estimated that approximately 85% of cases are caused by too much sun.[citation needed] Non-melanoma skin cancers are the most common skin cancers. The majority of these are called basal cell carcinomas. These are usually localised growths caused by excessive cumulative exposure to the sun and do not tend to spread.
For more information about Skin cancer, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with skin cancer
Switching immunosuppressants reduces cancer risk in kidney
Nov 02, 2009 |
not rated yet |
0
Switching to a newer type of immunosuppressant drug may reduce the high rate of skin cancer after kidney transplantation, according to research being presented at the American Society of Nephrology's 42nd Annual Meeting and ...
Do drug therapies raise risk of bladder cancer?
Oct 26, 2009 |
4 / 5 (1) |
0
In her most recent study of possible triggers of cancer among northern New England residents, Dartmouth epidemiologist Margaret R. Karagas, Ph.D., and her team identified an enhanced risk to the bladders of patients taking ...
Study reveals possible link between IBD therapy and skin cancer
Oct 26, 2009 |
not rated yet |
0
Findings from a new retrospective cohort study presented at the American College of Gastroenterology's 74th Annual Scientific meeting in San Diego indicate that patients with Inflammatory Bowel Disease (IBD), especially ...
Melanoma treatment options one step closer
Oct 20, 2009 |
not rated yet |
0
A targeted chemotherapy for the treatment of skin cancer is one step closer, after a team of University of Alberta researchers successfully synthesized a natural substance that shows exceptional potential to specifically ...
Resident physicians seldom trained in skin cancer examination
Oct 19, 2009 |
not rated yet |
0
Many resident physicians are not trained in skin cancer examinations, nor have they ever observed or practiced the procedure, according to a report in the October issue of Archives of Dermatology.
Researchers find demand for cosmetic and surgical procedures in dermatologic surgery rising rapidly
Oct 05, 2009 |
not rated yet |
0
Researchers from Boston University School of Medicine (BUSM) and the Laser and Skin Cancer Center of Indiana, (Carmel, Indiana), found that there has been a dramatic increase in the number of procedures performed and patient ...
FDA panel backs Schering-Plough cancer drug
Medicine & Health / Medications
Oct 05, 2009 |
not rated yet |
0
(AP) -- Federal health advisers voted 6-4 on Monday that the potential benefits of a Schering-Plough drug outweigh its toxic risks as a treatment for late-stage skin cancer.
New drug shows promise in the fight against malignant melanoma
Sep 29, 2009 |
5 / 5 (5) |
1
(PhysOrg.com) -- Gavin Robertson is not a man who uses the word ‘hate’ lightly, but he makes no secret of his desire to slay the dragon that is malignant melanoma.
New study resolves the mysterious origin of Merkel cells
Sep 28, 2009 |
5 / 5 (3) |
0
A new study resolves a 130-year-old mystery over the developmental origin of specialized skin cells involved in touch sensation. The findings will appear in the October 5, 2009 issue of the Journal of Cell Bi ...
The Medical Minute: Robotic surgery for treatment of prostate cancer
Sep 25, 2009 |
not rated yet |
0
(PhysOrg.com) -- Prostate cancer is the most commonly diagnosed cancer in the United States (excluding skin cancers) and is second only to lung cancer as a contributor to cancer deaths in American men.
Merkel cell polyomavirus associated with Merkel cell carcinoma
Sep 23, 2009 |
not rated yet |
0
The Merkel cell polyomavirus (MCPyV) is the only human polyomavirus known to be associated with a rare skin cancer, known as Merkel cell carcinoma, according to a new study published online September 23 in the Journal of ...
Short-term stress enhances anti-tumor activity in mice, study shows
Sep 21, 2009 |
not rated yet |
1
Public speaking, anyone? Or maybe a big job interview? Dry your palms and take a deep, calming breath; there may be a silver lining. Researchers at the Stanford University School of Medicine have shown that, at least in laboratory ...
Ozone hole smaller in 2009 than 2008: WMO
Space & Earth / Earth Sciences
Sep 16, 2009 |
not rated yet |
0
The World Meteorological Organisation said Wednesday that the ozone hole is expected to be smaller in 2009 than a year ago.
Novel anti-cancer drug yields positive response in people with advanced skin, brain cancer
Sep 02, 2009 |
5 / 5 (1) |
0
The Hedgehog signaling pathway is involved in a preliminary study and case report describing positive responses to an experimental anticancer drug in a majority of people with advanced or metastatic basal cell skin cancers. ...
Immune defect is key to skin aging
Aug 28, 2009 |
4 / 5 (2) |
0
Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have discovered why older people may be so vulnerable to cancer and infections in the skin. The team from UCL has shown in human volunteers ...
